Search hospitals > Georgia > Decatur
iResearch Atlanta, LLC
Claim this profileDecatur, Georgia 30030
Global Leader in Alzheimer's Disease
Global Leader in Depression
Conducts research for Major Depressive Disorder
Conducts research for Attention Deficit Hyperactivity Disorder (ADHD)
Conducts research for Schizophrenia
139 reported clinical trials
2 medical researchers
Summary
iResearch Atlanta, LLC is a medical facility located in Decatur, Georgia. This center is recognized for care of Alzheimer's Disease, Depression, Major Depressive Disorder, Attention Deficit Hyperactivity Disorder (ADHD), Schizophrenia and other specialties. iResearch Atlanta, LLC is involved with conducting 139 clinical trials across 88 conditions. There are 2 research doctors associated with this hospital, such as Kimball Johnson, MD and Saundra Maass-Robinson, MD.Area of expertise
1Alzheimer's Disease
Global LeaderAβ1-42 positive
Aβ1-40 positive
Stage II
2Depression
Global LeaderMGH-ATRQ
SARS-CoV-2
Selective Serotonin Reuptake Inhibitors (SSRI)
Top PIs
Kimball Johnson, MDiResearch Atlanta1 year of reported clinical research
Studies Alzheimer's Disease
Studies Attention Deficit Hyperactivity Disorder (ADHD)
14 reported clinical trials
14 drugs studied
Saundra Maass-Robinson, MDiResearch Atlanta1 year of reported clinical research
Studies Major Depressive Disorder
Studies Depression
2 reported clinical trials
1 drug studied
Clinical Trials running at iResearch Atlanta, LLC
Alzheimer's Disease
Depression
Obesity
Major Depressive Disorder
Migraine
Schizophrenia
Bipolar Disorder
Adolescent Health
Pediatric Migraine
Generalized Anxiety Disorder
Remternetug
for Alzheimer's Disease
This trial tests remternetug, a drug given by injection or IV, in people with early Alzheimer's disease. It aims to find out if the drug is safe and can help improve symptoms or slow down the disease.
Recruiting1 award Phase 34 criteria
Donanemab
for Alzheimer's Disease
This trial is testing donanemab, a medication aimed at helping people with Alzheimer's Disease by removing harmful protein clumps from their brains. Donanemab has shown promise in reducing these harmful proteins in Alzheimer's disease.
Recruiting1 award Phase 34 criteria
ABBV-916
for Early Alzheimer's Disease
This trial is testing a new drug called ABBV-916 to see if it can help people aged 50-90 who are in the early stages of Alzheimer's disease. Participants will receive the drug regularly over several months. The study aims to find out if the drug is safe and effective by monitoring changes in symptoms and side effects.
Recruiting0 awards Phase 26 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at iResearch Atlanta, LLC?
iResearch Atlanta, LLC is a medical facility located in Decatur, Georgia. This center is recognized for care of Alzheimer's Disease, Depression, Major Depressive Disorder, Attention Deficit Hyperactivity Disorder (ADHD), Schizophrenia and other specialties. iResearch Atlanta, LLC is involved with conducting 139 clinical trials across 88 conditions. There are 2 research doctors associated with this hospital, such as Kimball Johnson, MD and Saundra Maass-Robinson, MD.